Curileum Discovery

Company profile

Curileum Discovery company profile

Curileum Discovery is a biotechnology company in London discovering and developing novel therapeutics to intervene early in the development of severe GI diseases. ULI-015 is a novel small molecule that the company's scientists discovered that redirects precancerous cell production in polyps to healthy tissues. Daily oral treatment profoundly reduced polyps after three months in a porcine bowel cancer model (255 necrotic polyps, 1 progressive polyp). After six months, polyps regressed and fused with healthy tissue (571 regressed polyps, 1 progressive polyp). The company has developed a large scale, one-step method to isolate gram levels of ULI-015 from a plant source...... For more information, log in to dureach.com to view the full company profile.